APO Research
Talk to an analyst

APO RESEARCH · REPORT

Artificial Intelligence Medical Software

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Artificial Intelligence Medical Software Market Outlook and Growth Opportunities 2026

6 January 2026191 pages

Choose your research edition.

Industry ResearchArtificial Intelligence Medical Software Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Artificial Intelligence Medical Software Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Artificial Intelligence Medical Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Artificial Intelligence Medical Software Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Artificial Intelligence Medical Software Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Artificial Intelligence Medical Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Artificial Intelligence Medical Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Artificial Intelligence Medical Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Artificial Intelligence Medical Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Artificial Intelligence Medical Software market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Artificial Intelligence Medical Software market include 2bPrecise, CliniSys, Fabric Genomics, Flatiron Health, Foundation Medicine, Gene42, Human Longevity, IBM and Koninklijke Philips, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Artificial Intelligence Medical Software market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Artificial Intelligence Medical Software and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Artificial Intelligence Medical Software revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Artificial Intelligence Medical Software market.

Artificial Intelligence Medical Software Segment by Company

2bPrecise

CliniSys

Fabric Genomics

Flatiron Health

Foundation Medicine

Gene42

Human Longevity

IBM

Koninklijke Philips

LifeOmic Health

Pierian

SOPHiA GENETICS

Syapse

Tempus

Translational Software

Artificial Intelligence Medical Software Segment by Type

Image Recognition

Natural Language Processing

Others

Artificial Intelligence Medical Software Segment by Application

Drug Discovery

Precision Medicine

Others

Artificial Intelligence Medical Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Artificial Intelligence Medical Software status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Artificial Intelligence Medical Software key companies, revenue, market share, and recent developments.

3. To split the Artificial Intelligence Medical Software breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Artificial Intelligence Medical Software market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Artificial Intelligence Medical Software significant trends, drivers, influence factors in global and regions.

6. To analyze Artificial Intelligence Medical Software competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artificial Intelligence Medical Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Artificial Intelligence Medical Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artificial Intelligence Medical Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Artificial Intelligence Medical Software industry.

Chapter 3: Detailed analysis of Artificial Intelligence Medical Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Artificial Intelligence Medical Software in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Artificial Intelligence Medical Software in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Artificial Intelligence Medical Software Industry Trends Table 2. Artificial Intelligence Medical Software Industry Drivers Table 3. Artificial Intelligence Medical Software Industry Opportunities and Challenges Table 4. Artificial Intelligence Medical Software Industry Restraints Table 5. Global Artificial Intelligence Medical Software Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Artificial Intelligence Medical Software Revenue Share by Company (2021-2026) Table 7. Global Artificial Intelligence Medical Software Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Artificial Intelligence Medical Software Key Company Manufacturing Base & Headquarters Table 9. Global Artificial Intelligence Medical Software Company, Product Type & Application Table 10. Global Artificial Intelligence Medical Software Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Artificial Intelligence Medical Software by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Image Recognition Table 15. Significant Companies of Natural Language Processing Table 16. Significant Companies of Others Table 17. Global Artificial Intelligence Medical Software Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Artificial Intelligence Medical Software Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Artificial Intelligence Medical Software Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Artificial Intelligence Medical Software Sales Value Share by Type (2021-2026) Table 21. Global Artificial Intelligence Medical Software Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Drug Discovery Table 23. Significant Companies of Precision Medicine Table 24. Significant Companies of Others Table 25. Global Artificial Intelligence Medical Software Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Artificial Intelligence Medical Software Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Artificial Intelligence Medical Software Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Artificial Intelligence Medical Software Sales Value Share by Application (2021-2026) Table 29. Global Artificial Intelligence Medical Software Sales Value Share by Application (2027-2032) Table 30. Global Artificial Intelligence Medical Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Artificial Intelligence Medical Software Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Artificial Intelligence Medical Software Sales Value Share by Region (2021-2026) Table 33. Global Artificial Intelligence Medical Software Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Artificial Intelligence Medical Software Sales Value Share by Region (2027-2032) Table 35. Global Artificial Intelligence Medical Software Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Artificial Intelligence Medical Software Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Artificial Intelligence Medical Software Sales Value Market Share by Country (2021-2026) Table 38. Global Artificial Intelligence Medical Software Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Artificial Intelligence Medical Software Sales Value Market Share by Country (2027-2032) Table 40. 2bPrecise Company Information Table 41. 2bPrecise Business Overview Table 42. 2bPrecise Artificial Intelligence Medical Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. 2bPrecise Artificial Intelligence Medical Software Product Portfolio Table 44. 2bPrecise Recent Development Table 45. CliniSys Company Information Table 46. CliniSys Business Overview Table 47. CliniSys Artificial Intelligence Medical Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. CliniSys Artificial Intelligence Medical Software Product Portfolio Table 49. CliniSys Recent Development Table 50. Fabric Genomics Company Information Table 51. Fabric Genomics Business Overview Table 52. Fabric Genomics Artificial Intelligence Medical Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Fabric Genomics Artificial Intelligence Medical Software Product Portfolio Table 54. Fabric Genomics Recent Development Table 55. Flatiron Health Company Information Table 56. Flatiron Health Business Overview Table 57. Flatiron Health Artificial Intelligence Medical Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Flatiron Health Artificial Intelligence Medical Software Product Portfolio Table 59. Flatiron Health Recent Development Table 60. Foundation Medicine Company Information Table 61. Foundation Medicine Business Overview Table 62. Foundation Medicine Artificial Intelligence Medical Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Foundation Medicine Artificial Intelligence Medical Software Product Portfolio Table 64. Foundation Medicine Recent Development Table 65. Gene42 Company Information Table 66. Gene42 Business Overview Table 67. Gene42 Artificial Intelligence Medical Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Gene42 Artificial Intelligence Medical Software Product Portfolio Table 69. Gene42 Recent Development Table 70. Human Longevity Company Information Table 71. Human Longevity Business Overview Table 72. Human Longevity Artificial Intelligence Medical Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Human Longevity Artificial Intelligence Medical Software Product Portfolio Table 74. Human Longevity Recent Development Table 75. IBM Company Information Table 76. IBM Business Overview Table 77. IBM Artificial Intelligence Medical Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. IBM Artificial Intelligence Medical Software Product Portfolio Table 79. IBM Recent Development Table 80. Koninklijke Philips Company Information Table 81. Koninklijke Philips Business Overview Table 82. Koninklijke Philips Artificial Intelligence Medical Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Koninklijke Philips Artificial Intelligence Medical Software Product Portfolio Table 84. Koninklijke Philips Recent Development Table 85. LifeOmic Health Company Information Table 86. LifeOmic Health Business Overview Table 87. LifeOmic Health Artificial Intelligence Medical Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. LifeOmic Health Artificial Intelligence Medical Software Product Portfolio Table 89. LifeOmic Health Recent Development Table 90. Pierian Company Information Table 91. Pierian Business Overview Table 92. Pierian Artificial Intelligence Medical Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Pierian Artificial Intelligence Medical Software Product Portfolio Table 94. Pierian Recent Development Table 95. SOPHiA GENETICS Company Information Table 96. SOPHiA GENETICS Business Overview Table 97. SOPHiA GENETICS Artificial Intelligence Medical Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. SOPHiA GENETICS Artificial Intelligence Medical Software Product Portfolio Table 99. SOPHiA GENETICS Recent Development Table 100. Syapse Company Information Table 101. Syapse Business Overview Table 102. Syapse Artificial Intelligence Medical Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Syapse Artificial Intelligence Medical Software Product Portfolio Table 104. Syapse Recent Development Table 105. Tempus Company Information Table 106. Tempus Business Overview Table 107. Tempus Artificial Intelligence Medical Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Tempus Artificial Intelligence Medical Software Product Portfolio Table 109. Tempus Recent Development Table 110. Translational Software Company Information Table 111. Translational Software Business Overview Table 112. Translational Software Artificial Intelligence Medical Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Translational Software Artificial Intelligence Medical Software Product Portfolio Table 114. Translational Software Recent Development Table 115. Research Programs/Design for This Report Table 116. Authors List of This Report Table 117. Secondary Sources Table 118. Primary Sources List of Figures Figure 1. Artificial Intelligence Medical Software Product Image Figure 2. Global Artificial Intelligence Medical Software Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Artificial Intelligence Medical Software Market Size (2021-2032) & (US$ Million) Figure 4. Global Artificial Intelligence Medical Software Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Image Recognition Image Figure 8. Natural Language Processing Image Figure 9. Others Image Figure 10. Global Artificial Intelligence Medical Software Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Artificial Intelligence Medical Software Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Artificial Intelligence Medical Software Sales Value Share by Type (2021-2032) Figure 13. Drug Discovery Image Figure 14. Precision Medicine Image Figure 15. Others Image Figure 16. Global Artificial Intelligence Medical Software Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Artificial Intelligence Medical Software Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Artificial Intelligence Medical Software Sales Value Share by Application (2021-2032) Figure 19. Global Artificial Intelligence Medical Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Artificial Intelligence Medical Software Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Artificial Intelligence Medical Software Sales Value (2021-2032) & (US$ Million) Figure 22. North America Artificial Intelligence Medical Software Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Artificial Intelligence Medical Software Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Artificial Intelligence Medical Software Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Artificial Intelligence Medical Software Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Artificial Intelligence Medical Software Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Artificial Intelligence Medical Software Sales Value (2021-2032) & (US$ Million) Figure 28. South America Artificial Intelligence Medical Software Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Artificial Intelligence Medical Software Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Artificial Intelligence Medical Software Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Artificial Intelligence Medical Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Artificial Intelligence Medical Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Artificial Intelligence Medical Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Artificial Intelligence Medical Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Artificial Intelligence Medical Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Artificial Intelligence Medical Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Artificial Intelligence Medical Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Artificial Intelligence Medical Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Artificial Intelligence Medical Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Artificial Intelligence Medical Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Artificial Intelligence Medical Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Artificial Intelligence Medical Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Artificial Intelligence Medical Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Artificial Intelligence Medical Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Artificial Intelligence Medical Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Artificial Intelligence Medical Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Artificial Intelligence Medical Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Artificial Intelligence Medical Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Artificial Intelligence Medical Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Artificial Intelligence Medical Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Artificial Intelligence Medical Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Artificial Intelligence Medical Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Artificial Intelligence Medical Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Artificial Intelligence Medical Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Artificial Intelligence Medical Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Artificial Intelligence Medical Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Artificial Intelligence Medical Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Artificial Intelligence Medical Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Artificial Intelligence Medical Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Artificial Intelligence Medical Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Artificial Intelligence Medical Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Artificial Intelligence Medical Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Artificial Intelligence Medical Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Artificial Intelligence Medical Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Artificial Intelligence Medical Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Artificial Intelligence Medical Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Artificial Intelligence Medical Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Artificial Intelligence Medical Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Artificial Intelligence Medical Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Artificial Intelligence Medical Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Artificial Intelligence Medical Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Artificial Intelligence Medical Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Artificial Intelligence Medical Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Artificial Intelligence Medical Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Artificial Intelligence Medical Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Artificial Intelligence Medical Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Artificial Intelligence Medical Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Artificial Intelligence Medical Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Artificial Intelligence Medical Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Artificial Intelligence Medical Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Artificial Intelligence Medical Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Artificial Intelligence Medical Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Artificial Intelligence Medical Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Artificial Intelligence Medical Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Artificial Intelligence Medical Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Artificial Intelligence Medical Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Artificial Intelligence Medical Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Artificial Intelligence Medical Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Artificial Intelligence Medical Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Artificial Intelligence Medical Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Artificial Intelligence Medical Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Artificial Intelligence Medical Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Artificial Intelligence Medical Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Artificial Intelligence Medical Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Artificial Intelligence Medical Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Artificial Intelligence Medical Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Artificial Intelligence Medical Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Artificial Intelligence Medical Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Artificial Intelligence Medical Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Artificial Intelligence Medical Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Artificial Intelligence Medical Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Artificial Intelligence Medical Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Artificial Intelligence Medical Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Artificial Intelligence Medical Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Artificial Intelligence Medical Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Artificial Intelligence Medical Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Artificial Intelligence Medical Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Artificial Intelligence Medical Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Artificial Intelligence Medical Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Artificial Intelligence Medical Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Artificial Intelligence Medical Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Artificial Intelligence Medical Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Artificial Intelligence Medical Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Artificial Intelligence Medical Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Image Recognition
  • Natural Language Processing
  • Others
Applications
  • Drug Discovery
  • Precision Medicine
  • Others
Companies covered
  • 2bPrecise
  • CliniSys
  • Fabric Genomics
  • Flatiron Health
  • Foundation Medicine
  • Gene42
  • Human Longevity
  • IBM
  • Koninklijke Philips
  • LifeOmic Health
  • Pierian
  • SOPHiA GENETICS
  • Syapse
  • Tempus
  • Translational Software

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Artificial Intelligence Medical Software Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Artificial Intelligence Medical Software Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Artificial Intelligence Medical Software Market Dynamics
  1. 2.1 Artificial Intelligence Medical Software Industry Trends
  2. 2.2 Artificial Intelligence Medical Software Industry Drivers
  3. 2.3 Artificial Intelligence Medical Software Industry Opportunities and Challenges
  4. 2.4 Artificial Intelligence Medical Software Industry Restraints
3 Artificial Intelligence Medical Software Market by Company
  1. 3.1 Global Artificial Intelligence Medical Software Company Revenue Ranking in 2025
  2. 3.2 Global Artificial Intelligence Medical Software Revenue by Company (2021-2026)
  3. 3.3 Global Artificial Intelligence Medical Software Company Ranking (2024-2026)
  4. 3.4 Global Artificial Intelligence Medical Software Company Manufacturing Base and Headquarters
  5. 3.5 Global Artificial Intelligence Medical Software Company Product Type and Application
  6. 3.6 Global Artificial Intelligence Medical Software Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Artificial Intelligence Medical Software Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Artificial Intelligence Medical Software Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Artificial Intelligence Medical Software Market by Type
  1. 4.1 Artificial Intelligence Medical Software Type Introduction
  2. 4.1.1 Image Recognition
  3. 4.1.2 Natural Language Processing
  4. 4.1.3 Others
  5. 4.2 Global Artificial Intelligence Medical Software Sales Value by Type
  6. 4.2.1 Global Artificial Intelligence Medical Software Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Artificial Intelligence Medical Software Sales Value by Type (2021-2032)
  8. 4.2.3 Global Artificial Intelligence Medical Software Sales Value Share by Type (2021-2032)
5 Artificial Intelligence Medical Software Market by Application
  1. 5.1 Artificial Intelligence Medical Software Application Introduction
  2. 5.1.1 Drug Discovery
  3. 5.1.2 Precision Medicine
  4. 5.1.3 Others
  5. 5.2 Global Artificial Intelligence Medical Software Sales Value by Application
  6. 5.2.1 Global Artificial Intelligence Medical Software Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Artificial Intelligence Medical Software Sales Value by Application (2021-2032)
  8. 5.2.3 Global Artificial Intelligence Medical Software Sales Value Share by Application (2021-2032)
6 Artificial Intelligence Medical Software Regional Value Analysis
  1. 6.1 Global Artificial Intelligence Medical Software Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Artificial Intelligence Medical Software Sales Value by Region (2021-2032)
  3. 6.2.1 Global Artificial Intelligence Medical Software Sales Value by Region: 2021-2026
  4. 6.2.2 Global Artificial Intelligence Medical Software Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Artificial Intelligence Medical Software Sales Value (2021-2032)
  7. 6.3.2 North America Artificial Intelligence Medical Software Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Artificial Intelligence Medical Software Sales Value (2021-2032)
  10. 6.4.2 Europe Artificial Intelligence Medical Software Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Artificial Intelligence Medical Software Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Artificial Intelligence Medical Software Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Artificial Intelligence Medical Software Sales Value (2021-2032)
  16. 6.6.2 South America Artificial Intelligence Medical Software Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Artificial Intelligence Medical Software Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Artificial Intelligence Medical Software Sales Value Share by Country, 2025 VS 2032
7 Artificial Intelligence Medical Software Country-level Value Analysis
  1. 7.1 Global Artificial Intelligence Medical Software Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Artificial Intelligence Medical Software Sales Value by Country (2021-2032)
  3. 7.2.1 Global Artificial Intelligence Medical Software Sales Value by Country (2021-2026)
  4. 7.2.2 Global Artificial Intelligence Medical Software Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Artificial Intelligence Medical Software Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Artificial Intelligence Medical Software Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Artificial Intelligence Medical Software Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Artificial Intelligence Medical Software Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Artificial Intelligence Medical Software Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Artificial Intelligence Medical Software Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Artificial Intelligence Medical Software Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Artificial Intelligence Medical Software Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Artificial Intelligence Medical Software Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Artificial Intelligence Medical Software Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Artificial Intelligence Medical Software Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Artificial Intelligence Medical Software Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Artificial Intelligence Medical Software Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Artificial Intelligence Medical Software Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Artificial Intelligence Medical Software Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Artificial Intelligence Medical Software Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Artificial Intelligence Medical Software Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Artificial Intelligence Medical Software Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Artificial Intelligence Medical Software Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Artificial Intelligence Medical Software Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Artificial Intelligence Medical Software Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Artificial Intelligence Medical Software Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Artificial Intelligence Medical Software Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Artificial Intelligence Medical Software Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Artificial Intelligence Medical Software Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Artificial Intelligence Medical Software Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Artificial Intelligence Medical Software Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Artificial Intelligence Medical Software Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Artificial Intelligence Medical Software Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Artificial Intelligence Medical Software Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Artificial Intelligence Medical Software Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Artificial Intelligence Medical Software Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Artificial Intelligence Medical Software Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Artificial Intelligence Medical Software Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Artificial Intelligence Medical Software Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Artificial Intelligence Medical Software Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Artificial Intelligence Medical Software Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Artificial Intelligence Medical Software Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Artificial Intelligence Medical Software Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Artificial Intelligence Medical Software Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Artificial Intelligence Medical Software Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Artificial Intelligence Medical Software Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Artificial Intelligence Medical Software Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Artificial Intelligence Medical Software Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Artificial Intelligence Medical Software Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Artificial Intelligence Medical Software Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Artificial Intelligence Medical Software Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Artificial Intelligence Medical Software Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Artificial Intelligence Medical Software Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Artificial Intelligence Medical Software Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Artificial Intelligence Medical Software Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Artificial Intelligence Medical Software Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Artificial Intelligence Medical Software Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Artificial Intelligence Medical Software Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Artificial Intelligence Medical Software Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Artificial Intelligence Medical Software Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Artificial Intelligence Medical Software Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Artificial Intelligence Medical Software Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Artificial Intelligence Medical Software Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Artificial Intelligence Medical Software Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Artificial Intelligence Medical Software Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Artificial Intelligence Medical Software Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Artificial Intelligence Medical Software Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Artificial Intelligence Medical Software Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Artificial Intelligence Medical Software Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Artificial Intelligence Medical Software Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Artificial Intelligence Medical Software Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Artificial Intelligence Medical Software Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Artificial Intelligence Medical Software Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Artificial Intelligence Medical Software Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Artificial Intelligence Medical Software Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Artificial Intelligence Medical Software Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Artificial Intelligence Medical Software Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Artificial Intelligence Medical Software Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Artificial Intelligence Medical Software Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Artificial Intelligence Medical Software Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Artificial Intelligence Medical Software Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Artificial Intelligence Medical Software Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Artificial Intelligence Medical Software Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Artificial Intelligence Medical Software Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Artificial Intelligence Medical Software Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Artificial Intelligence Medical Software Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Artificial Intelligence Medical Software Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Artificial Intelligence Medical Software Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 2bPrecise
  2. 8.1.1 2bPrecise Company Information
  3. 8.1.2 2bPrecise Business Overview
  4. 8.1.3 2bPrecise Artificial Intelligence Medical Software Revenue and Gross Margin (2021-2026)
  5. 8.1.4 2bPrecise Artificial Intelligence Medical Software Product Portfolio
  6. 8.1.5 2bPrecise Recent Developments
  7. 8.2 CliniSys
  8. 8.2.1 CliniSys Company Information
  9. 8.2.2 CliniSys Business Overview
  10. 8.2.3 CliniSys Artificial Intelligence Medical Software Revenue and Gross Margin (2021-2026)
  11. 8.2.4 CliniSys Artificial Intelligence Medical Software Product Portfolio
  12. 8.2.5 CliniSys Recent Developments
  13. 8.3 Fabric Genomics
  14. 8.3.1 Fabric Genomics Company Information
  15. 8.3.2 Fabric Genomics Business Overview
  16. 8.3.3 Fabric Genomics Artificial Intelligence Medical Software Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Fabric Genomics Artificial Intelligence Medical Software Product Portfolio
  18. 8.3.5 Fabric Genomics Recent Developments
  19. 8.4 Flatiron Health
  20. 8.4.1 Flatiron Health Company Information
  21. 8.4.2 Flatiron Health Business Overview
  22. 8.4.3 Flatiron Health Artificial Intelligence Medical Software Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Flatiron Health Artificial Intelligence Medical Software Product Portfolio
  24. 8.4.5 Flatiron Health Recent Developments
  25. 8.5 Foundation Medicine
  26. 8.5.1 Foundation Medicine Company Information
  27. 8.5.2 Foundation Medicine Business Overview
  28. 8.5.3 Foundation Medicine Artificial Intelligence Medical Software Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Foundation Medicine Artificial Intelligence Medical Software Product Portfolio
  30. 8.5.5 Foundation Medicine Recent Developments
  31. 8.6 Gene42
  32. 8.6.1 Gene42 Company Information
  33. 8.6.2 Gene42 Business Overview
  34. 8.6.3 Gene42 Artificial Intelligence Medical Software Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Gene42 Artificial Intelligence Medical Software Product Portfolio
  36. 8.6.5 Gene42 Recent Developments
  37. 8.7 Human Longevity
  38. 8.7.1 Human Longevity Company Information
  39. 8.7.2 Human Longevity Business Overview
  40. 8.7.3 Human Longevity Artificial Intelligence Medical Software Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Human Longevity Artificial Intelligence Medical Software Product Portfolio
  42. 8.7.5 Human Longevity Recent Developments
  43. 8.8 IBM
  44. 8.8.1 IBM Company Information
  45. 8.8.2 IBM Business Overview
  46. 8.8.3 IBM Artificial Intelligence Medical Software Revenue and Gross Margin (2021-2026)
  47. 8.8.4 IBM Artificial Intelligence Medical Software Product Portfolio
  48. 8.8.5 IBM Recent Developments
  49. 8.9 Koninklijke Philips
  50. 8.9.1 Koninklijke Philips Company Information
  51. 8.9.2 Koninklijke Philips Business Overview
  52. 8.9.3 Koninklijke Philips Artificial Intelligence Medical Software Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Koninklijke Philips Artificial Intelligence Medical Software Product Portfolio
  54. 8.9.5 Koninklijke Philips Recent Developments
  55. 8.10 LifeOmic Health
  56. 8.10.1 LifeOmic Health Company Information
  57. 8.10.2 LifeOmic Health Business Overview
  58. 8.10.3 LifeOmic Health Artificial Intelligence Medical Software Revenue and Gross Margin (2021-2026)
  59. 8.10.4 LifeOmic Health Artificial Intelligence Medical Software Product Portfolio
  60. 8.10.5 LifeOmic Health Recent Developments
  61. 8.11 Pierian
  62. 8.11.1 Pierian Company Information
  63. 8.11.2 Pierian Business Overview
  64. 8.11.3 Pierian Artificial Intelligence Medical Software Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Pierian Artificial Intelligence Medical Software Product Portfolio
  66. 8.11.5 Pierian Recent Developments
  67. 8.12 SOPHiA GENETICS
  68. 8.12.1 SOPHiA GENETICS Company Information
  69. 8.12.2 SOPHiA GENETICS Business Overview
  70. 8.12.3 SOPHiA GENETICS Artificial Intelligence Medical Software Revenue and Gross Margin (2021-2026)
  71. 8.12.4 SOPHiA GENETICS Artificial Intelligence Medical Software Product Portfolio
  72. 8.12.5 SOPHiA GENETICS Recent Developments
  73. 8.13 Syapse
  74. 8.13.1 Syapse Company Information
  75. 8.13.2 Syapse Business Overview
  76. 8.13.3 Syapse Artificial Intelligence Medical Software Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Syapse Artificial Intelligence Medical Software Product Portfolio
  78. 8.13.5 Syapse Recent Developments
  79. 8.14 Tempus
  80. 8.14.1 Tempus Company Information
  81. 8.14.2 Tempus Business Overview
  82. 8.14.3 Tempus Artificial Intelligence Medical Software Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Tempus Artificial Intelligence Medical Software Product Portfolio
  84. 8.14.5 Tempus Recent Developments
  85. 8.15 Translational Software
  86. 8.15.1 Translational Software Company Information
  87. 8.15.2 Translational Software Business Overview
  88. 8.15.3 Translational Software Artificial Intelligence Medical Software Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Translational Software Artificial Intelligence Medical Software Product Portfolio
  90. 8.15.5 Translational Software Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst